Further, a 2023 study demonstrated hepatocyte nuclear factor 4 gamma (HNF4G) binds to the ERK3 promoter and increases ERK3 protein level, increases AKT phosphorylation at S473 and reduces cisplatin sensitivity in lung adenocarcinoma cells [65]. Here, MAPK6 is linked to lung adenocarcinoma.